about
Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cellsRetinoblastomaA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead.Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastomaSupraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastomaChorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions.Consequences of delayed diagnosis in treatment of retinoblastomaSecondary skull base malignancies in survivors of retinoblastoma: the memorial sloan kettering cancer center experience.Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients.Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor modelExpression of C-kit in retinoblastoma: a potential therapeutic target.Perinatal characteristics and retinoblastomaCombined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells.A case-control study of paternal occupational exposures and the risk of childhood sporadic bilateral retinoblastoma.Molecular genetics of RB1--the retinoblastoma gene.Mutation risk associated with paternal and maternal age in a cohort of retinoblastoma survivorsThe quasi-integrated porous polyethylene implant in pediatric patients enucleated for retinoblastoma.Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment.Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.Delay in the diagnosis of retinoblastoma in China.Effects of NF-κB and hypoxia on the biological behavior of Y79 retinoblastoma cells.The effect of imatinib mesylate on the proliferation, invasive ability, and radiosensitivity of retinoblastoma cell lines.Experimental research on wild-type p53 plasmid transfected into retinoblastoma cells and tissues using an ultrasound microbubble intensifier.Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial.Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy.RB pocket domain B mutation frequency in Malaysia.Full-field electroretinography under general anesthesia in retinoblastoma.Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.Retinoblastoma presenting with a cheek mass.Hope in sight for retinoblastoma.Etoposide Upregulates Survival Favoring Sphingosine-1-Phosphate in Etoposide-Resistant Retinoblastoma Cells.Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.Treating retinoblastoma in the first year of life in a national tertiary paediatric hospital in Mexico.Recent advancements in the management of retinoblastoma and uveal melanoma.Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis.RetinoblastomaSuperselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey
P2860
Q21245735-AA3FED50-2412-4972-851B-8CDDFDB00AEFQ21558539-1C046312-3C73-4E07-8AAF-3B7F38859E5CQ30252766-DC6A5ED2-2BCE-4206-8CAE-6E581D65B4EFQ33273757-5E9222BE-FA40-4CE3-B3E7-A49A7EBB2868Q33613662-8FE1B8E3-DF63-474F-8C4C-608F7531B834Q33705736-ACC24A31-1BA3-4161-96DB-DDFC2CA5016DQ33771714-F21710A4-6FA4-4379-A40D-74D1ADD09AABQ33839406-84D7312A-899C-40C8-8F3C-A5FC31828660Q34534139-8740BA50-CD65-4D6B-A52F-B152130F42EEQ35118530-3AB838CF-D878-46D9-826E-EB221329BA53Q35853544-A86E4B2D-46B0-4D9C-A207-841F01DE40E3Q35923749-DB973E59-1DAE-47F2-8BDB-4F088706DC34Q35979171-D4E1F9E9-E6B8-4C6E-9A62-CEC341646A1DQ36172104-E244E18C-4647-429B-B720-55C0A1BA0097Q36196113-DFCC51E7-6A6D-4CC3-939A-5884ACF0BC50Q36321693-8FFAC6F7-81F7-431F-B07F-54209421F3CEQ36883028-F1A6E8DE-F561-4128-8568-15E33C09D8F1Q37039806-5DFC66D8-5486-438F-ADAF-B2B4ADDB03D7Q37346472-73449DDE-9817-41CE-BDEC-3D410C75DEC7Q37351646-8F871960-1EDF-4AD1-922C-696B7786BB77Q38001657-9098820B-151A-409D-A8F3-B9018EFF9ECBQ38260425-4FEF140A-9B0F-47B3-8BEB-AC6029A7D052Q38429600-13293F93-873D-4E22-8137-C7267080BF59Q38875102-12349A4E-5539-4C3A-A1BD-9D00513DB1D3Q39244182-3CD11794-6195-4966-9EED-CC766B600315Q39659049-DB6377F3-D3F7-4620-9E89-1110CB13D67DQ40954188-C3BD6AA5-BFC9-409C-AA51-BA3F8278BB0AQ41054784-C8B025EB-56DA-4015-9B71-599AC892F128Q43011222-E33A3DD3-1399-4547-A2C0-433957964133Q43526277-4AC58CBA-95F9-47B3-828B-AFD1D0B11BE0Q44974340-19787093-DBF6-4C7D-87D9-391FA996F97CQ46480627-8F6A422B-5F59-4F60-BF60-24EE1348EFFCQ47583454-23BD9900-9795-45D9-A282-593F7C017E9EQ47588678-49AF0651-CA48-46A2-B30B-7F5272B7A041Q48710342-509A9103-161E-4C5F-B067-55F0F665E804Q53526922-B8DADC07-1148-4EC8-B231-77BF00097B63Q55143412-3B6DE049-C75E-43B1-901A-20E96F8A6C0DQ55396897-DF1CBF91-6DF9-43D1-90B4-0086829C119BQ58347703-FFE3F888-4D22-4E33-ACEE-4262DE56F4EDQ58841503-F39EE1D9-E853-4A2F-8CB8-8195FBE26CDA
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Update on retinoblastoma.
@ast
Update on retinoblastoma.
@en
Update on retinoblastoma.
@nl
type
label
Update on retinoblastoma.
@ast
Update on retinoblastoma.
@en
Update on retinoblastoma.
@nl
prefLabel
Update on retinoblastoma.
@ast
Update on retinoblastoma.
@en
Update on retinoblastoma.
@nl
P1433
P1476
Update on retinoblastoma.
@en
P2093
David H Abramson
P304
P356
10.1097/00006982-200412000-00002
P577
2004-12-01T00:00:00Z